Impact of homologous recombination deficiency on CDK4/6 inhibitor sensitivity in HR+/HER2-breast cancerDaniela Haas(Medical University of Graz), Marija Balić(University of Pittsburgh)Research SquareAugust 13, 202510.21203/rs.3.rs-7253927/v1Cited by 0SaveCiteExport RISWatch citationsRelated PapersChronic Oxidative Stress Promotes Molecular Changes Associated with Epithelial Mesenchymal Transition, NRF2, and Breast Cancer Stem Cell Phenotype|Antioxidants|2019|34